A majority of
people with chronic myeloid leukemia (CML) do
well with treatments. But a few will develop
serious side effects or develop drug resistance.
Listen to experts describe what can be
done.
If you no longer wish to receive this
newsletter, please UNSUBSCRIBE.
If you received this newsletter from a
colleague or friend and would like to join the mailing
list, please SUBSCRIBE.
To view your current newsletter
subscriptions, unsubscribe, change your address or
subscribe to more newsletters, please visit the subscription management center.
Please add Healthology to your address
book or safe list so our messages get to your inbox and
are not filtered as bulk mail. The addresses to add are:
weekly@healthology.com and
healthupdate@healthology.com
